Prospective trial of efficiency and safety of fibrin sealant criofit after autologous breast reconstruction in stages I–III breast cancer
Open Access
- 12 October 2022
- journal article
- research article
- Published by Publishing House ABV Press in Bone and soft tissue sarcomas, tumors of the skin
- Vol. 14 (3) , 26-32
Abstract
Introduction. Breast cancer is the most common cancer. Success in early diagnostic and system treatment is achieved. All the same mastectomy with reconstruction is the best option for some patients. Seroma is common complication after reconstructive plastic surgery.Aim. To analyze efficiency of using fibrin sealant criofit at donor zone after autologous breast reconstruction in decreasing seroma incidences.Materials and methods. This is randomised controlled clinical trial of fibrin sealant criofit effect on assessing of seroma incidences, timing of drain removal at donor zone after autologous breast reconstruction in comparison with control group. Surgical technic, drains removal criteria and patients characteristics were identical in both groups.Results. Average drain fluid volume on the first day (150.9 ± 40.7 ml vs 190.6 ± 60.7 ml; p 0.001) and second day (152.6 ± 53.3 ml vs 184.9 ± 90.3 ml; p = 0.04) after surgery was significantly lower in experimental group. Average number of days of drainage in criofit group was significantly lower (6.3 ± 1.1 days vs 7.4 ± 2.1 days; p = 0.01). Seroma incidences in experimental group was lower in comparison with control group (10 % vs 23 %). It was statistically significant.Conclusion. We aimed to asses the efficiency of fibrin sealant criofit at donor zone after autologous breast reconstruction. Criofit decrese the volume of serous draining in first days after surgery, number of days of drainage and seroma incidences significantly. But more powerful clinical trials are needed. Study limitations are small sample, changes in surgery team, small observation period.Keywords
This publication has 17 references indexed in Scilit:
- Seroma and Quilting Suture at the Donor Site of the TRAM Flap in Breast ReconstructionAnnals of Plastic Surgery, 2014
- Fibrin Sealant: The Only Approved Hemostat, Sealant, and Adhesive—a Laboratory and Clinical PerspectiveISRN Surgery, 2014
- The Evolution of Perforator Flap Breast Reconstruction: Twenty Years after the First DIEP FlapJournal of Reconstructive Microsurgery, 2013
- The role of fibrin glue instillation under skin flaps in the prevention of seroma formation and related morbidities following breast and axillary surgery for breast cancer: A meta‐analysisJournal of Surgical Oncology, 2012
- Systematic review and meta-analysis of the use of fibrin sealant to prevent seroma formation after breast cancer surgeryBritish Journal of Surgery, 2006
- DIEP and Pedicled TRAM Flaps: A Comparison of OutcomesPlastic and Reconstructive Surgery, 2006
- Use of Abdominal Quilting Sutures for Seroma Prevention in TRAM Flap Reconstruction:Annals of Plastic Surgery, 2005
- Defining the “Gold Standard” in Breast Reconstruction with Abdominal TissuePlastic and Reconstructive Surgery, 2004
- Twenty-Year Follow-up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy plus Irradiation for the Treatment of Invasive Breast CancerNew England Journal of Medicine, 2002
- Twenty-Year Follow-up of a Randomized Study Comparing Breast-Conserving Surgery with Radical Mastectomy for Early Breast CancerNew England Journal of Medicine, 2002